Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Regulatory  ·  Weekly Digest - 25 July to 31 July 2026
Gilead announces CHMP recommendation for Trodelvy + Keytruda in 1L PD-(L)1+ mTNBC

Weekly Digest – July 2026 Weekly Digest – July 2026 24 July 2026: Gilead announces CHMP recommendation for Trodelvy + Keytruda in 1L PD-(L)1+ mTNBC Gilead announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 25 July to 31 July 2026
EU CHMP recommends Enhertu plus Pertuzumab for 1L HER2 metastatic Breast cancer

Weekly Digest – July 2026 Weekly Digest – July 2026 24 July 2026: EU CHMP recommends Enhertu plus Pertuzumab for 1L HER2 metastatic Breast cancer AstraZeneca and Daiichi Sankyo announced that the European Medicines Agency’s Committee for Medicinal Products for […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 18 July to 24 July 2026
Biokin Pharma announces approval of Iza-bren in China for the treatment of recurrent/metastatic ESCC

Weekly Digest – July 2026 Weekly Digest – July 2026 17 July 2026: Biokin Pharma announces approval of Iza-bren in China for the treatment of recurrent/metastatic ESCC Biokin Pharma announced that China’s NMPA has approved Iza-bren for the treatment of […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 18 July to 24 July 2026
NMPA accepts New Drug Application for Trastuzumab Envedotin injection

Weekly Digest – July 2026 Weekly Digest – July 2026 17 July 2026: NMPA accepts New Drug Application for Trastuzumab Envedotin injection CSPC Pharmaceutical Group announced that China’s NMPA has accepted the new drug application for Trastuzumab envedotin injection, a […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 18 July to 24 July 2026
Medilink announces NMPA acceptance of marketing application for Tam-Peli in 3L+ NPC

Weekly Digest – July 2026 Weekly Digest – July 2026 18 July 2026: Medilink announces NMPA acceptance of marketing application for Tam-Peli in 3L+ NPC MediLink Therapeutics announced that China’s NMPA has accepted the new drug application for Tam-Peli, its […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 18 July to 24 July 2026
SEC recommends approval to Enhertu for two additional indications in India

Weekly Digest – July 2026 Weekly Digest – July 2026 21 July 2026: SEC recommends approval to Enhertu for two additional indications in India India’s Subject Expert Committee has recommended approval of two additional indications for AstraZeneca and Daiichi Sankyo’s […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 18 July to 24 July 2026
Telix doses first patient in phase 3 LUTEON trial of TLX250-Tx for Renal cancer

Weekly Digest – July 2026 Weekly Digest – July 2026 21 July 2026: Telix doses first patient in phase 3 LUTEON trial of TLX250-Tx for Renal cancer Telix Pharmaceuticals announced the first patient dosing in the pivotal phase 3 LUTEON […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 18 July to 24 July 2026
Samsung Bioepis enters into a commercial license agreement with IntoCell for an ADC candidate

Weekly Digest – July 2026 Weekly Digest – July 2026 22 July 2026: Samsung Bioepis enters into a commercial license agreement with IntoCell for an ADC candidate Samsung Bioepis has entered into a commercial license agreement with IntoCell for SBE303, […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 11 July to 17 July 2026
U.S. FDA approves PADCEV plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility

Weekly Digest – July 2026 Weekly Digest – July 2026 10 July 2026: U.S. FDA approves PADCEV plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility The U.S. FDA has approved PADCEV plus KEYTRUDA as neoadjuvant […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 11 July to 17 July 2026
SOTIO receives FDA Fast Track Designation for CDH17-targeting ADC SOT109 for CRC

Weekly Digest – July 2026 Weekly Digest – July 2026 14 July 2026: SOTIO receives FDA Fast Track Designation for CDH17-targeting ADC SOT109 for CRC SOTIO has received U.S. FDA Fast Track Designation for SOT109, its CDH17-targeting antibody-drug conjugate, for […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous789101112131415Next ›Last »
Page 11 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id